Pediatric Cardiac Intensive Care Society 2014 Consensus Statement: Pharmacotherapies in Cardiac Critical Care Immune Therapy.

Pediatr Crit Care Med

1Division of Pediatric Cardiology, Department of Pediatrics, Rady Children's Hospital San Diego, UC San Diego School of Medicine, San Diego, CA. 2Department of Pharmacy, Texas Children's Hospital, Houston, TX. 3Division of Cardiology, Department of Pediatric Medicine, Texas Children's Hospital, Baylor College of Medicine, Houston, TX. 4Department of Pharmacy, Morgan Stanley Children's Hospital of New York-Presbyterian, Columbia University Medical Center, New York, NY.

Published: March 2016

Objective: In this Consensus Statement, we review the etiology and pathophysiology of inflammatory processes seen in critically ill children with cardiac disease. Immunomodulatory therapies aimed at improving outcomes in patients with myocarditis, heart failure, and transplantation are extensively reviewed.

Data Sources: The author team experience and along with an extensive review of the medical literature were used as data sources.

Data Synthesis: The authors synthesized the data in the literature to present current immumodulatory therapies. For each drug, the physiologic rationale, mechanism of action, and pharmacokinetics are synthesized, and the evidence in the literature to support the therapy is discussed.

Conclusions: Immunomodulation has a crucial role in the treatment of certain pediatric cardiac diseases. Immunomodulatory treatments that have been used to treat myocarditis include corticosteroids, IV immunoglobulin, cyclosporine, and azathioprine. Contemporary outcomes of pediatric transplant recipients have improved over the past few decades, partly related to improvements in immunomodulatory therapy to prevent rejection of the donor heart. Immunosuppression therapy is commonly divided into induction, maintenance, and acute rejection therapy. Common induction medications include antithymocyte globulin, muromonab-CD3, and basiliximab. Maintenance therapy includes chronic medications that are used daily to prevent rejection episodes. Examples of maintenance medications are corticosteroids, cyclosporine, tacrolimus, sirolimus, everolimus, azathioprine, and mycophenolate mofetil. Rejection of the donor heart is diagnosed either by clinically or by biopsy and is treated with intensification of immunosuppression.

Download full-text PDF

Source
http://dx.doi.org/10.1097/PCC.0000000000000626DOI Listing

Publication Analysis

Top Keywords

pediatric cardiac
8
consensus statement
8
prevent rejection
8
rejection donor
8
donor heart
8
therapy
6
cardiac intensive
4
intensive care
4
care society
4
society 2014
4

Similar Publications

Aim: To evaluate the impact of heart rate-guided basic resuscitation compared to Helping Babies Breathe on neonatal outcomes and resuscitation practices in the Democratic Republic of the Congo.

Methods: We conducted a pre-post clinical trial comparing heart rate-guided basic resuscitation to Helping Babies Breathe in three facilities, enrolling in-born neonates ≥28 weeks gestation. We collected observational data during a convenience sample of resuscitations and extracted clinical data from the medical record for all participants.

View Article and Find Full Text PDF

Epicardial Pacemaker Lead Related Cardiac Strangulation: The Importance of Early Recognition.

Pediatr Cardiol

January 2025

Cardiothoracic Department, Children's Health Ireland at Crumlin, Dublin, Ireland.

Lead strangulation is a dangerous complication of epicardial pacemaker insertion. This complication has been increasingly highlighted lately. Our institution has recently identified four cases over the past five years.

View Article and Find Full Text PDF

Pediatric patients undergoing cardiothoracic surgery are at increased risk for health care-associated infections, especially surgical site infections (SSIs). Delayed sternal closures are associated with prolonged lengths of stay and contribute to infection risks and morbidities. At a single-site academic pediatric center, we created an SSI-prevention bundle targeting the preoperative, intraoperative, and postoperative care periods.

View Article and Find Full Text PDF

Background: Vulvar squamous cell carcinoma incidence is increasing, especially among women under 60, largely attributed to human papillomavirus infections. Precursor pre-invasive vulvar lesions are frequently underdiagnosed. Routine vulvar inspection during cervical cancer screening could offer an opportunity for the detection of these lesions.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!